Inventor · disambiguated record
Uta Höpken
Also filed as: HÖPKEN UTA · HÖPKEN UTA ELISABETH
6 granted patents·10 citations·filing 2013–2024
74Inventor score
Files withMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT4MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN1Max-Delbrück-Centrum für Molekulare Medizin 1
Top patents by PatentIndex Score
6 records- 0182US10189906B2Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseasesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2013·Granted Jan 29, 2019·7 cites·8 claims
- 0279US10745486B2Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseasesMax-Delbrück-Centrum für Molekulare Medizin ·Filed 2018·Granted Aug 18, 2020·3 cites·9 claims
- 0371US12351640B2Chimeric antigen receptor and CAR-T cells that bind BCMAMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2024·Granted Jul 8, 2025·0 cites·20 claims
- 0465US11667722B2Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseasesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2020·Granted Jun 6, 2023·0 cites·11 claims
- 0547US11643468B2Chimeric antigen receptors and CAR-T cells that bind CXCR5 and methods of use thereof to treat medical disordersMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2018·Granted May 9, 2023·0 cites·24 claims
- 0643US12048718B2Chimeric antigen receptor and CAR-T cells that bind BCMAMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2017·Granted Jul 30, 2024·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Uta Höpken files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →